Form 4: LeMaitre Vascular Inc. Executive Trent G. Kamke Reports Acquisition of Dividend Equivalent Rights
SEC Form 4
Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reports the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.
Summary
- On May 30, 2024, Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular Inc., reported the acquisition of dividend equivalent rights.
- These rights are associated with restricted stock unit (RSU) and performance share unit (PSU) awards previously granted to Kamke.
- The dividend equivalent rights accrued on awards granted on various dates, including December 20, 2019, December 2, 2020, December 11, 2021, December 12, 2022, and December 8, 2023.
- The acquired dividend equivalent rights are the economic equivalent of shares of LeMaitre Vascular Inc.'s common stock.
- The total dividend equivalent rights acquired are 0.346, 0.647, 1.2018, 1.8387, 1.8387, and 2.0952, corresponding to the respective RSU and PSU grants.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the document is a standard regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative performance.
Positives
- The acquisition of dividend equivalent rights indicates continued alignment of executive compensation with shareholder value.
- The vesting of these rights is tied to the vesting of underlying RSU and PSU awards, incentivizing long-term performance.
Industry Context
Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions and executive compensation.
Stakeholder Impact
- Shareholders may view the acquisition of dividend equivalent rights as part of the company's compensation strategy to align executive interests with shareholder value.
Key Dates
| Date | Description |
|---|---|
| 12/20/2019 | Date of restricted stock unit award grant associated with dividend equivalent rights. |
| 12/02/2020 | Date of restricted stock unit award grant associated with dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award grant associated with dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit award grants associated with dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award grant associated with dividend equivalent rights. |
| 05/30/2024 | Date of the reported transaction: acquisition of dividend equivalent rights. |
| 06/03/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.